Evaluation of Conditional Cash Transfers (CCTs) for Immunization
Testing the Effect of Mobile Conditional Cash Transfers (mCCTs) of Different Schedules and Amounts on Routine Childhood Immunization Coverage and Timeliness in Pakistan: A Randomized Control Trial.
1 other identifier
interventional
11,197
1 country
1
Brief Summary
Like many developing countries, Pakistan faces a public health challenge of low and incomplete immunization rates of children, only 54% of children aged 12 to 24 months are fully immunized, which leaves children susceptible to vaccine-preventable diseases. The Expanded Program on Immunization (EPI) is a low-cost and effective health intervention, but the uptake is low, delayed, and completion rates are poor. Door-to-door campaigns can increase coverage, but are extremely expensive. Incentive-based approaches have been rigorously demonstrated to effectively increase take-up and completion rates of immunization, and there is substantial evidence that small incentives can have a large impact on the take up of preventative health behavior in general. There are two major constraints to scaling these findings, however. This study will attempt to find the most effective incentive design that helps increase the coverage of full immunization rates among children between the ages of 0 - 24 months in the city of Karachi, Pakistan. The study proposes to conduct a randomized control trial involving small conditional cash transfers (mCCTs) to determine the optimal CCT amount (high versus low), schedule (flat versus increasing) and design (lottery versus sure payment) that would lead to the highest increase in immunization rates. Interactive Research and Development's digital immunization registry will be used to enrol and randomize the study participants and generate CCTs disbursed through a mobile money transfer platform and mobile top - ups . The three year study will be conducted in Karachi, Pakistan enrolling a sample of 11,200 children, 0-2 years of age. The study aims to provide evidence regarding the most cost-effective way to structure incentives in terms of size, schedule, and design; and address the challenge of delivering small incentives in a way that is inexpensive, logistically simple, and not subject to leakage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 6, 2017
CompletedFirst Submitted
Initial submission to the registry
November 22, 2017
CompletedFirst Posted
Study publicly available on registry
November 29, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 4, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 4, 2020
CompletedJuly 29, 2020
July 1, 2020
2.4 years
November 22, 2017
July 27, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of fully immunized children
This will be the proportion of Fully immunized children under two years of age. A fully immunized child (FIC) will be one who received the entire series of EPI recommended vaccines by 2 years of age: one dose of BCG, 3 doses of each OPV, Pentavalent \& PCV immunizations, and 2 doses of Measles vaccines. This is a commonly used indicator in WUENIC, DHS reports and EPI survey reports.
When the participants reach 2 years of age
Secondary Outcomes (5)
Penta3, Polio3, PCV3, or Measles1 coverage at 12 to 23 months
Children vaccinated between the age of 12 to 23 months
Penta3, Polio3, PCV3, or Measles1 coverage at 12 months
Children vaccinated by 12 months of age
Proportion of fully immunized children at 12 months
When the children enroled reach 12 months of age
Proportion timely receipt of vaccine doses.
Vaccination date within 4 weeks of the due date
Immunization system utilization (drop-out rate)
This will be noted for when the child exceeds two years of age and remains unvaccinated
Study Arms (12)
Low Flat Rate without Lottery
EXPERIMENTALThe intervention consists of receiving a small cash incentive of $0.80 on every vaccine along with 3 SMS reminders before, at and after the due date. The incentive will be sent via mobile top - up.
Low Flat Rate with Lottery
EXPERIMENTALThe intervention consists of a 20% chance of receiving a small cash incentive of $4.00 on every vaccine along with 3 SMS reminders before, at and after the due date. The incentive will be sent via mobile top - up.
Low Sharp Rate without Lottery
EXPERIMENTALThe intervention consists of receiving a small cash incentive of $0.75 on the BCG/Penta-1/Penta-2 vaccine and $1.00 on the Measles-1/Measles 2 vaccine along with 3 SMS reminders before, at and after the due date. The incentive will be sent via mobile top - up.
Low Sharp Rate with Lottery
EXPERIMENTALThe intervention consists of a 20% chance of receiving a small cash incentive of $3.75 on the BCG/Penta-1/Penta-2 vaccine and $5.00 on the Measles-1/Measles 2 vaccine along with 3 SMS reminders before, at and after the due date. The incentive will be sent via mobile top - up.
High Flat Rate without Lottery
EXPERIMENTALThe intervention consists of receiving a large cash incentive of $2.40 on every vaccine along with 3 SMS reminders before, at and after the due date. The incentive will be sent via mobile top - up.
High Flat Rate with Lottery
EXPERIMENTALThe intervention consists of a 20% chance of receiving a large cash incentive of $12.00 on every vaccine along with 3 SMS reminders before, at and after the due date. The incentive will be sent via mobile top - up.
High Sharp Rate without Lottery
EXPERIMENTALThe intervention consists of receiving a large cash incentive of $2.25 on the BCG/Penta-1/Penta-2 vaccine and $3.00 on the Measles-1/Measles 2 vaccine along with 3 SMS reminders before, at and after the due date. The incentive will be sent via mobile top - up.
High Sharp Rate with Lottery
EXPERIMENTALThe intervention consists of a 20% chance of receiving a large cash incentive of $11.25 on the BCG/Penta-1/Penta-2 vaccine and $15.00 on the Measles-1/Measles 2 vaccine along with 3 SMS reminders before, at and after the due date. The incentive will be sent via mobile top - up.
Easypaisa Flat Rate without Lottery
EXPERIMENTALThe intervention consists of receiving a large cash incentive of $2.40 on every vaccine along with 3 SMS reminders before, at and after the due date. The incentive will be sent via mobile money transfer i.e. easypaisa
Easypaisa Flat Rate with Lottery
EXPERIMENTALThe intervention consists of a 20% chance of receiving a large cash incentive of $12.00 on every vaccine along with 3 SMS reminders before, at and after the due date. The incentive will be sent via mobile money transfer i.e. easypaisa
SMS Reminder Only
EXPERIMENTALThe intervention consists of only sending 3 SMS reminders before, at and after the due date.
Control
NO INTERVENTIONNo intervention will be provided either in the form of cash incentive or reminder SMS. Vaccination facilities will be provided as per usual.
Interventions
Conditional cash transfer provided via mobile airtime and easypaisa along with SMS reminders to increase immunization coverage and timeliness
Three SMS reminders for immunization provided before, at and after the due date respectively
Eligibility Criteria
You may qualify if:
- Children between 0 - 23 months of age visiting the EPI center for BCG/OPV-0 or Pentavalent-1/Polio-1/PCV-1 or Pentavalent-2/Polio-2/PCV-2 vaccination.
- Children permanently residing within Korangi Town, Karachi and planto remain there for the next three years.
- Caregiver accompanying the child can provide a valid mobile phone number at the time of enrolment
You may not qualify if:
- Children visiting the EPI center for Pentavalent-2 or Measles-1 or Measles 2
- Children born out of multiple births i.e twins or triplets
- Children not residing or planning to move out of Korangi in the next three years
- Children accompanied by caregivers unable to provide a phone number
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Interactive Research and Developmentlead
- Abdul Latif Jameel Poverty Action Labcollaborator
- Global Innovation Fundcollaborator
Study Sites (1)
BHU 51-B
Karachi, Sindh, Pakistan
Related Publications (2)
Chandir S, Siddiqi DA, Abdullah S, Duflo E, Khan AJ, Glennerster R. Small mobile conditional cash transfers (mCCTs) of different amounts, schedules and design to improve routine childhood immunization coverage and timeliness of children aged 0-23 months in Pakistan: An open label multi-arm randomized controlled trial. EClinicalMedicine. 2022 Jun 25;50:101500. doi: 10.1016/j.eclinm.2022.101500. eCollection 2022 Aug.
PMID: 35784436DERIVEDPalmer MJ, Henschke N, Bergman H, Villanueva G, Maayan N, Tamrat T, Mehl GL, Glenton C, Lewin S, Fonhus MS, Free C. Targeted client communication via mobile devices for improving maternal, neonatal, and child health. Cochrane Database Syst Rev. 2020 Jul 14;8(8):CD013679. doi: 10.1002/14651858.CD013679.
PMID: 32813276DERIVED
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Aamir Khan
Interactive Research and Development (IRD)
- PRINCIPAL INVESTIGATOR
Subhash Chandir
Interactive Research and Development (IRD)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- The participant allocation sequence will be concealed from the study staff responsible for screening and enrolling participants through the use of real time phone based randomization sequence.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Primary Investigator
Study Record Dates
First Submitted
November 22, 2017
First Posted
November 29, 2017
Study Start
November 6, 2017
Primary Completion
April 4, 2020
Study Completion
April 4, 2020
Last Updated
July 29, 2020
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share